Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026161
Filing Date
2024-08-13
Accepted
2024-08-13 08:05:44
Documents
89
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20240630_10q.htm   iXBRL 10-Q 1770181
2 EXHIBIT 10.1 ex_707552.htm EX-10.1 106701
3 EXHIBIT 31.1 ex_687738.htm EX-31.1 17126
4 EXHIBIT 31.2 ex_687739.htm EX-31.2 17111
5 EXHIBIT 32.1 ex_687740.htm EX-32.1 6489
6 EXHIBIT 32.2 ex_687741.htm EX-32.2 6474
  Complete submission text file 0001437749-24-026161.txt   7285376

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20240630.xsd EX-101.SCH 70775
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20240630_cal.xml EX-101.CAL 46814
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20240630_def.xml EX-101.DEF 409888
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20240630_lab.xml EX-101.LAB 344288
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20240630_pre.xml EX-101.PRE 446764
92 EXTRACTED XBRL INSTANCE DOCUMENT urgn20240630_10q_htm.xml XML 970631
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 241198862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)